{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:29:46Z","timestamp":1782818986577,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,2]]},"DOI":"10.7759\/cureus.106324","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:17:15Z","timestamp":1775143035000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of Drug-to-Drug Interactions on Patients With Advanced Cancer in Palliative Care Settings"],"prefix":"10.7759","author":[{"given":"Hassan M","family":"Albadour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal  S","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman  A","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia A","family":"Basiouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Srrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohoud S","family":"AlAmri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Alshaqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.01.001","article-title":"Hospice and palliative care: an overview","volume":"104","author":"Tatum PE","year":"2020","unstructured":"Tatum PE, Mills SS. Hospice and palliative care: an overview. Med Clin North Am. 2020, 104:359-73. 10.1016\/j.mcna.2020.01.001","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-7568(22)00031-9","article-title":"A longevity society requires integrated palliative care models for historically excluded older people","volume":"3","author":"Rosa WE","year":"2022","unstructured":"Rosa WE, Bhadelia A, Knaul FM, Travers JL, Metheny N, Fulmer T. A longevity society requires integrated palliative care models for historically excluded older people. Lancet Healthy Longev. 2022, 3:227-8. 10.1016\/s2666-7568(22)00031-9","journal-title":"Lancet Healthy Longev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/nop2.1683","article-title":"Perceptions of healthcare professional about the \"PACE Steps to Success\" palliative care program for long-term care: a\u00a0qualitative study in Switzerland","volume":"10","author":"Charmillot PA","year":"2023","unstructured":"Charmillot PA, Van den Block L, Oosterveld-Vlug M, Pautex S. Perceptions of healthcare professional about the \"PACE Steps to Success\" palliative care program for long-term care: a\u00a0qualitative study in Switzerland. Nurs Open. 2023, 10:4413-23. 10.1002\/nop2.1683","journal-title":"Nurs Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105465","article-title":"Global and regional prevalence of polypharmacy and related factors, 1997-2022: an umbrella review","volume":"124","author":"Kim S","year":"2024","unstructured":"Kim S, Lee H, Park J, Kang J, Rahmati M, Rhee SY, Yon DK. Global and regional prevalence of polypharmacy and related factors, 1997-2022: an umbrella review. Arch Gerontol Geriatr. 2024, 124:105465. 10.1016\/j.archger.2024.105465","journal-title":"Arch Gerontol Geriatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.09.003","article-title":"The burden of polypharmacy in patients near the end of life","volume":"51","author":"McNeil MJ","year":"2016","unstructured":"McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016, 51:178-83.e2. 10.1016\/j.jpainsymman.2015.09.003","journal-title":"J Pain Symptom Manage"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.06.009","article-title":"Potential drug interactions in cancer patients receiving supportive care exclusively","volume":"35","author":"Riechelmann RP","year":"2008","unstructured":"Riechelmann RP, Zimmermann C, Chin SN, Wang L, O'Carroll A, Zarinehbaf S, Krzyzanowska MK. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage. 2008, 35:535-43. 10.1016\/j.jpainsymman.2007.06.009","journal-title":"J Pain Symptom Manage"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0998-4","article-title":"Potential for drug interactions in hospitalized cancer patients","volume":"56","author":"Riechelmann RP","year":"2005","unstructured":"Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005, 56:286-90. 10.1007\/s00280-004-0998-4","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk130","article-title":"Potential drug interactions and duplicate prescriptions among cancer patients","volume":"99","author":"Riechelmann RP","year":"2007","unstructured":"Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007, 99:592-600. 10.1093\/jnci\/djk130","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311412231","article-title":"Drug interactions in palliative care--it's more than cytochrome P450","volume":"26","author":"Gaertner J","year":"2012","unstructured":"Gaertner J, Ruberg K, Schlesiger G, Frechen S, Voltz R. Drug interactions in palliative care--it's more than cytochrome P450. Palliat Med. 2012, 26:813-25. 10.1177\/0269216311412231","journal-title":"Palliat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261971","article-title":"Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany","volume":"35","author":"Frechen S","year":"2012","unstructured":"Frechen S, Zoeller A, Ruberg K, Voltz R, Gaertner J. Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany. Drug Saf. 2012, 35:745-58. 10.1007\/BF03261971","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-015-0094-3","article-title":"Medication use during end-of-life care in a palliative care centre","volume":"37","author":"Masman AD","year":"2015","unstructured":"Masman AD, van Dijk M, Tibboel D, Baar FP, Math\u00f4t RA. Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm. 2015, 37:767-75. 10.1007\/s11096-015-0094-3","journal-title":"Int J Clin Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.001651","article-title":"Hydrocodone, oxycodone, and morphine metabolism and drug-drug interactions","volume":"387","author":"Coates S","year":"2023","unstructured":"Coates S, Lazarus P. Hydrocodone, oxycodone, and morphine metabolism and drug-drug interactions. J Pharmacol Exp Ther. 2023, 387:150-69. 10.1124\/jpet.123.001651","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2014-000767","article-title":"Analysis of drug interactions at the end of life","volume":"5","author":"Morgan NA","year":"2015","unstructured":"Morgan NA, Rowett D, Currow DC. Analysis of drug interactions at the end of life. BMJ Support Palliat Care. 2015, 5:281-6. 10.1136\/bmjspcare-2014-000767","journal-title":"BMJ Support Palliat Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton RT","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020, 3:17. 10.1038\/s41746-020-0221-y","journal-title":"NPJ Digit Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1641222","article-title":"Contributions from the 2017 literature on clinical decision support","volume":"27","author":"Koutkias V","year":"2018","unstructured":"Koutkias V, Bouaud J. Contributions from the 2017 literature on clinical decision support. Yearb Med Inform. 2018, 27:122-8. 10.1055\/s-0038-1641222","journal-title":"Yearb Med Inform"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/14604582241263242","article-title":"Override rate of drug-drug interaction alerts in clinical decision support systems: a brief systematic review and meta-analysis","volume":"30","author":"Felisberto M","year":"2024","unstructured":"Felisberto M, Lima GD, Celuppi IC, et al.. Override rate of drug-drug interaction alerts in clinical decision support systems: a brief systematic review and meta-analysis. Health Informatics J. 2024, 30:10.1177\/14604582241263242","journal-title":"Health Informatics J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-021-01346-8","article-title":"Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex(\u00ae) and Lexicomp(\u00ae): a retrospective observational study","volume":"44","author":"Abbas A","year":"2022","unstructured":"Abbas A, Al-Shaibi S, Sankaralingam S, Awaisu A, Kattezhathu VS, Wongwiwatthananukit S, Owusu YB. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex(\u00ae) and Lexicomp(\u00ae): a retrospective observational study. Int J Clin Pharm. 2022, 44:348-56. 10.1007\/s11096-021-01346-8","journal-title":"Int J Clin Pharm"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients","volume":"7","author":"Bruera E","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991, 7:6-9.","journal-title":"J Palliat Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2023.2253223","article-title":"Potential drug interactions in terminally-ill cancer patients, a report from the Middle East","volume":"37","author":"Mahzoni H","year":"2023","unstructured":"Mahzoni H, Naghsh E, Sharifi M, Moghaddas A, Momenzadeh M, Moghaddas A. Potential drug interactions in terminally-ill cancer patients, a report from the Middle East. J Pain Palliat Care Pharmacother. 2023, 37:278-85. 10.1080\/15360288.2023.2253223","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.5812\/jjhs.102131","article-title":"Critical care pharmacist using free drug-interaction checker mobile apps can ensure medication safety in critically ill patients","volume":"12","author":"Hasan MJ","year":"2020","unstructured":"Hasan MJ, Rabbani R, Bachar SC. Critical care pharmacist using free drug-interaction checker mobile apps can ensure medication safety in critically ill patients. Jundishapur J Health Sci. 2020, 12:e102131.","journal-title":"Jundishapur J Health Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400244-impact-of-drug-to-drug-interactions-on-patients-with-advanced-cancer-in-palliative-care-settings","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:17:16Z","timestamp":1775143036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400244-impact-of-drug-to-drug-interactions-on-patients-with-advanced-cancer-in-palliative-care-settings"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.106324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}